Navigation Links
Discovery demonstrates potential MS therapy could kill brain cells
Date:5/6/2011

Edmonton Researchers with the Faculty of Medicine & Dentistry at the University of Alberta have discovered that some "protective" T-cells can kill neurons. This finding is significant because a specific type of T-cell therapy is being touted in the medical community as a potential treatment for MS and other autoimmune conditions.

Dr. Fabrizio Giuliani and his post-doctoral fellow, Yohannes Haile, both from the Division of Neurology, collaborated on this research which was recently published in the Journal of Leukocyte Biology, a peer-reviewed medical journal.

"Using T-cells has been seen as a potential treatment for autoimmune diseases," says Dr. Giuliani. "But these cells that are supposed to be regulatory, when activated, they can kill. In our hands, at least, they were able to kill neurons. So this is very important. In MS literature, they were starting to talk about using the infusion of these cells as treatment. This area needs to be studied more before these cells are used as a therapy for MS patients."

The finding was serendipitous, says Giuliani.

"We were using some of the cells that we have described here as a control in our project. And then the T-cells did something interesting, something we weren't expecting. In fact, we were expecting the exact opposite response with these cells.

"We were looking at how a specific type of T-cell could prevent neuronal death and then we found out they were doing the killingThese are the best findings when you are expecting something different and then you observe an amazing phenomenon."

T-cells are very important their primary role is to attack foreign viruses or bacteria and to regulate or maintain immune system tolerance. However, when T-cell tolerance is disrupted, they can cause autoimmune diseases.

Researchers in the medical community have thought if they could carefully collect regulatory T-cells and inject them into patients with autoimmune diseases, these T-cells could keep autoimmune diseases under control. Work with lab models that had MS and were treated with T-cells was promising. However, recent studies of human cells have shown humans have different subpopulations of T-cells some of which do not have a regulatory function.

Giuliani and Haile worked with different subpopulations of T-cells and discovered some were toxic to neurons. Giuliani and his colleague are the first medical researchers to demonstrate that activating a specific type of T-cell can kill brain cells.

They want to continue their work in this area to determine what causes some T-cells to behave this way.

"We want to take the research further. We want to continue this story in an attempt to try and solve the mystery."


'/>"/>

Contact: Raquel Maurier
raquel.maurier@ualberta.ca
780-492-5986
University of Alberta Faculty of Medicine & Dentistry
Source:Eurekalert

Related biology news :

1. Worm discovery could help 1 billion people worldwide
2. New discovery could green up hundreds of everyday products
3. Discovery identifies elaborate G-protein network in plants
4. A chance discovery may revolutionize hydrogen production
5. A world first: The discovery of a common genetic cause of autism and epilepsy
6. Discovery of protein that alters nutrition of breast cancer cells
7. Missouri Botanical Garden makes rare discovery of plant genus
8. Discovery of a biochemical basis for broccolis cancer-fighting ability
9. Discovery of source of glycogen manufacturing errors sheds light on fatal disease
10. MU researchers believe discovery could lead to testing that displaces colonoscopies
11. Discovery of blood proteins that are red flags for ectopic pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2016)... , March 10, 2016   Unisys Corporation (NYSE: ... Border Protection (CBP) is testing its biometric identity solution ... Diego to help identify certain non-U.S. citizens leaving ... The test, designed to help determine the efficiency and accuracy ... in February and will run until May 2016. --> ...
(Date:3/8/2016)...   Valencell , the leading innovator in ... secured $11M in Series D financing. The investment ... fund being launched by UAE-based financial services company ... TDF Ventures and WSJ Joshua Fund. Valencell plans ... growth and accelerate its pioneering innovation in accurate ...
(Date:3/2/2016)... , March 2, 2016 ... announced the addition of the  "Global Biometrics ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... to grow at a CAGR of around ... ) has announced the addition of ...
Breaking Biology News(10 mins):
(Date:5/5/2016)... ... 05, 2016 , ... ProMIS Neurosciences (“ProMIS” or the “Company”) ... it has identified a fourth in a series of novel potential therapeutic targets ... of Alzheimer’s disease (AD). , “This discovery is an important milestone ...
(Date:5/4/2016)... ... ... Proove Biosciences, Inc. , the commercial and research leader in personalized pain ... partnership is designed to advance research in pain genetics in an effort to bring ... new agreement, researchers at Proove Biosciences are able to collaborate with Luda Diatechnko, MD, ...
(Date:5/4/2016)... ALBANY, New York , May 4, 2016 /PRNewswire/ ... published by Transparency Market Research "Metabolomics Market - Global ... - 2024", the metabolomics market is anticipated to expand ... to reach USD 2,494.8 million by 2024. ... known as metabolites, within cells, biofluids, tissues or organisms. ...
(Date:5/3/2016)... May 3, 2016 ... Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & ... Institutes, Diagnostics Centers), Fabrication Technology (Microarrays, Microfluidics) ... the market is expected to reach USD ... Billion in 2015, growing at a CAGR ...
Breaking Biology Technology: